ARK Genomic Revolution ETF
ARKG
286 hedge funds and large institutions have $609M invested in ARK Genomic Revolution ETF in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 65 increasing their positions, 103 reducing their positions, and 36 closing their positions.
8.35% more ownership
Funds ownership: 28.87% → 37.22% (+8.4%)
1% less capital invested
Capital invested by funds: $619M → $609M (-$9.24M)
5% less funds holding
Funds holding: 300 → 286 (-14)
25% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 36
37% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 103
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
59% less call options, than puts
Call options by funds: $49.5M | Put options by funds: $121M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$35.3M |
| 2 |
JP Morgan Chase
New York
|
+$24M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$15.9M |
| 4 |
Morgan Stanley
New York
|
+$10.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$9.15M |
| 2 |
Goldman Sachs
New York
|
-$8.92M |
| 3 |
Two Sigma Advisers
New York
|
-$7.29M |
| 4 |
Two Sigma Investments
New York
|
-$6.54M |
| 5 |
ACM
Atika Capital Management
New York
|
-$3.58M |
ARKG Hedge Fund Activity: Q1 2024 in Review
286 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2024, worth a combined $609M — down 1.5% from $619M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of ARKG and 27 opened new positions — a net loss of 9 holders — while 103 trimmed existing stakes and 65 added.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $35.3M. The largest seller was State of Wisconsin Investment Board, cutting an estimated $9.15M.
- 286 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2024, down from 300 in Q4 2023.
- Funds reported $609M of ARK Genomic Revolution ETF stock for Q1 2024, down 1.5% quarter-over-quarter.
- 27 funds opened new ARK Genomic Revolution ETF positions in Q1 2024 and 36 closed out, a net change of -9 holders.
- The largest ARK Genomic Revolution ETF buyer in Q1 2024 was BNP Paribas Financial Markets, an estimated $35.3M added.
- The largest ARK Genomic Revolution ETF seller in Q1 2024 was State of Wisconsin Investment Board, an estimated $9.15M sold.
Based on aggregated 13F filings for Q1 2024.